HomeAgenda
Register
Register
Register

ServiceUpdated on 20 August 2025

in vitro characterisation of the nanomedicines

About

in vitro characterisation of the nanomedicine under development allowing specific and critical questions to be answered related to its toxicity, like cytotoxicity, cell viability, sensitization & irritation, etc.

Attached files

Organisation

PHOENIX -OITB gGmbH

Company (SME/startup) / 中小企業・スタートアップ

66802 Überherrn, Germany